Targeting the DNA damage response for cancer therapy by inhibiting the kinase Wee1
Cancer cells typically heavily rely on the G2/M checkpoint to survive endogenous and
exogenous DNA damage, such as genotoxic stress due to genome instability or radiation …
exogenous DNA damage, such as genotoxic stress due to genome instability or radiation …
DNA damage response inhibitors: An avenue for TNBC treatment
J **, Z Tao, J Cao, T Li, X Hu - … et Biophysica Acta (BBA)-Reviews on …, 2021 - Elsevier
The DNA damage response (DDR) is critical for the maintenance of genomic stability by
sensing DNA damage, regulating cell cycle and initiating DNA repair. Drugs targeting DDR …
sensing DNA damage, regulating cell cycle and initiating DNA repair. Drugs targeting DDR …
FBXL12 degrades FANCD2 to regulate replication recovery and promote cancer cell survival under conditions of replication stress
Fanconi anemia (FA) signaling, a key genomic maintenance pathway, is activated in
response to replication stress. Here, we report that phosphorylation of the pivotal pathway …
response to replication stress. Here, we report that phosphorylation of the pivotal pathway …
DNA damage response in breast cancer and its significant role in guiding novel precise therapies
J Li, Z Jia, L Dong, H Cao, Y Huang, H Xu, Z **e… - Biomarker …, 2024 - Springer
DNA damage response (DDR) deficiency has been one of the emerging targets in treating
breast cancer in recent years. On the one hand, DDR coordinates cell cycle and signal …
breast cancer in recent years. On the one hand, DDR coordinates cell cycle and signal …
Identification of a Notch transcriptomic signature for breast cancer
Abstract Background Dysregulated Notch signalling contributes to breast cancer
development and progression, but validated tools to measure the level of Notch signalling in …
development and progression, but validated tools to measure the level of Notch signalling in …
Targeting WEE1 inhibits growth of breast cancer cells that are resistant to endocrine therapy and CDK4/6 inhibitors
Despite the success of antiestrogens in extending overall survival of patients with estrogen
receptor positive (ER+) breast tumors, resistance to these therapies is prevalent. ER+ tumors …
receptor positive (ER+) breast tumors, resistance to these therapies is prevalent. ER+ tumors …
An update of predictive biomarkers related to WEE1 inhibition in cancer therapy
Z Wang, W Li, F Li, R **ao - Journal of Cancer Research and Clinical …, 2024 - Springer
Purpose WEE1 is a crucial kinase involved in the regulation of G2/M checkpoint within the
cell cycle. This article aims to comprehensively review the existing knowledge on the …
cell cycle. This article aims to comprehensively review the existing knowledge on the …
Myt1 overexpression mediates resistance to cell cycle and DNA damage checkpoint kinase inhibitors
S Sokhi, CW Lewis, AB Bukhari, J Hadfield… - Frontiers in Cell and …, 2023 - frontiersin.org
Cell cycle checkpoint kinases serve as important therapeutic targets for various cancers.
When they are inhibited by small molecules, checkpoint abrogation can induce cell death or …
When they are inhibited by small molecules, checkpoint abrogation can induce cell death or …
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170)
We sought to evaluate the efficacy of WEE1 inhibitor adavosertib in patients with solid tumor
malignancies (cohort A) and clear cell renal cell carcinoma (ccRCC; cohort B) …
malignancies (cohort A) and clear cell renal cell carcinoma (ccRCC; cohort B) …
Autophagy and PTEN in DNA damage-induced senescence
A Sharma, A Almasan - Advances in cancer research, 2021 - Elsevier
The use of DNA-damaging agents such as radiotherapy and chemotherapy has been a
mainstay treatment protocol for many cancers, including lung and prostate. Recently, FDA …
mainstay treatment protocol for many cancers, including lung and prostate. Recently, FDA …